FilingSEC EDGAR8-K
Dermata Therapeutics Announces First Participant Enrollment in Acne Treatment Clinical Trial
· SEC accepted
StageClinical Trial
Filing content
The company announced the enrollment of the first participant in a clinical trial for its acne treatment, Tome Clearing Treatment, with an expected launch in the first half of 2027.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…